Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2014

01.07.2014 | Original Article – Cancer Research

Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients

verfasst von: Marco Johannes Battista, Cristina Cotarelo, Sina Jakobi, Joscha Steetskamp, Georgios Makris, Isabel Sicking, Veronika Weyer, Marcus Schmidt

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to evaluate the prognostic influence of epithelial cell adhesion molecule (EpCAM) in an unselected cohort of ovarian cancer (OC) patients.

Methods

Expression of EpCAM was determined by immunohistochemistry in an unselected cohort of 117 patients with OC. Univariable and multivariable Cox regression analyses adjusted for age, tumor stage, histological grading, histological subtype, postoperative tumor burden and completeness of chemotherapy were performed in order to determine the prognostic influence of EpCAM. The Kaplan–Meier method is used to estimate survival rates.

Results

Univariable Cox regression analysis showed that overexpression of EpCAM is associated with favorable prognosis in terms of progression-free survival (PFS) (p = 0.011) and disease-specific survival (DSS) (p = 0.003). In multivariable Cox regression analysis, overexpression of EpCAM retains its significance independent of established prognostic factors for longer PFS [hazard ratios (HR) 0.408, 95 % confidence interval (CI) 0.197–0.846, p = 0.003] but not for PFS (HR 0.666, 95 % CI 0.366–1.212, p = 0.183). Kaplan–Meier plots demonstrate an influence on 5-year PFS rates (0 vs. 27.6 %, p = 0.048) and DSS rates (11.8 vs. 54.0 %, p = 0.018).

Conclusions

These findings support the hypothesis that the expression of EpCAM is associated with favorable prognosis in OC.
Literatur
Zurück zum Zitat Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S et al (2011) Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity. Oncogene 30:3468–3476PubMedCrossRef Akita H, Nagano H, Takeda Y, Eguchi H, Wada H, Kobayashi S et al (2011) Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity. Oncogene 30:3468–3476PubMedCrossRef
Zurück zum Zitat Basak S, Speicher D, Eck S, Wunner W, Maul G, Simmons MS et al (1998) Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90:691–697PubMedCrossRef Basak S, Speicher D, Eck S, Wunner W, Maul G, Simmons MS et al (1998) Colorectal carcinoma invasion inhibition by CO17-1A/GA733 antigen and its murine homologue. J Natl Cancer Inst 90:691–697PubMedCrossRef
Zurück zum Zitat Battista MJ, Mantai N, Sicking I, Cotarelo C, Weyer V, Lebrecht A, Solbach C, Schmidt M (2014) Ki-67 as independent prognostic factor in an unselected cohort of patients with ovarian cancer—results of an explorative, retrospective study. Oncol Rep 31:2213–2219PubMed Battista MJ, Mantai N, Sicking I, Cotarelo C, Weyer V, Lebrecht A, Solbach C, Schmidt M (2014) Ki-67 as independent prognostic factor in an unselected cohort of patients with ovarian cancer—results of an explorative, retrospective study. Oncol Rep 31:2213–2219PubMed
Zurück zum Zitat Gadducci A, Cosio S, Tana R, Genazzani AR (2009) Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol 69:12–27PubMedCrossRef Gadducci A, Cosio S, Tana R, Genazzani AR (2009) Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol 69:12–27PubMedCrossRef
Zurück zum Zitat Gastl G, Spizzo G, Obrist P, Dünser M, Mikuz G (2000) Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356:1981–1982PubMedCrossRef Gastl G, Spizzo G, Obrist P, Dünser M, Mikuz G (2000) Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356:1981–1982PubMedCrossRef
Zurück zum Zitat Ghebeh H, Sleiman GM, Manogaran PS, Al-mazrou A, Barhoush E, Al-mohanna FH et al (2013) Profiling of normal and malignant breast tissue show CD44 high/CD24 low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers. BMC Cancer 13:289PubMedCentralPubMedCrossRef Ghebeh H, Sleiman GM, Manogaran PS, Al-mazrou A, Barhoush E, Al-mohanna FH et al (2013) Profiling of normal and malignant breast tissue show CD44 high/CD24 low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers. BMC Cancer 13:289PubMedCentralPubMedCrossRef
Zurück zum Zitat Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357PubMedCrossRef Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357PubMedCrossRef
Zurück zum Zitat Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ et al (2004) Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10:4427–4436PubMedCrossRef Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ et al (2004) Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10:4427–4436PubMedCrossRef
Zurück zum Zitat Jojović M, Adam E, Zangemeister-Wittke USU (1998) Epithelial glycoprotein-2 expression is subject to regulatory processes in epithelial–mesenchymal transitions during metastases: an investigation of human cancers transplanted into severe combined immunodeficient mice. Histochem J 30:732–739 Jojović M, Adam E, Zangemeister-Wittke USU (1998) Epithelial glycoprotein-2 expression is subject to regulatory processes in epithelial–mesenchymal transitions during metastases: an investigation of human cancers transplanted into severe combined immunodeficient mice. Histochem J 30:732–739
Zurück zum Zitat Kimura H, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y et al (2007) Prognostic significance of EpCAM expression in human esophageal cancer. Int J Oncol 30:171–179PubMed Kimura H, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y et al (2007) Prognostic significance of EpCAM expression in human esophageal cancer. Int J Oncol 30:171–179PubMed
Zurück zum Zitat Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO (1994) Ep-CAM: a human epithelial antigen is a homophilic cell–cell adhesion molecule. J Cell Biol 125:437–446PubMedCrossRef Litvinov SV, Velders MP, Bakker HA, Fleuren GJ, Warnaar SO (1994) Ep-CAM: a human epithelial antigen is a homophilic cell–cell adhesion molecule. J Cell Biol 125:437–446PubMedCrossRef
Zurück zum Zitat Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F et al (1997) Epithelial cell adhesion molecule (Ep-CAM) modulates cell–cell interactions mediated by classic cadherins. J Cell Biol 139:1337–1348PubMedCentralPubMedCrossRef Litvinov SV, Balzar M, Winter MJ, Bakker HA, Briaire-de Bruijn IH, Prins F et al (1997) Epithelial cell adhesion molecule (Ep-CAM) modulates cell–cell interactions mediated by classic cadherins. J Cell Biol 139:1337–1348PubMedCentralPubMedCrossRef
Zurück zum Zitat Münz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O (2004) The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23:5748–5758PubMedCrossRef Münz M, Kieu C, Mack B, Schmitt B, Zeidler R, Gires O (2004) The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation. Oncogene 23:5748–5758PubMedCrossRef
Zurück zum Zitat Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA et al (2004) EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64:5818–5824PubMedCrossRef Osta WA, Chen Y, Mikhitarian K, Mitas M, Salem M, Hannun YA et al (2004) EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy. Cancer Res 64:5818–5824PubMedCrossRef
Zurück zum Zitat Pietzner K, Woopen H, Richter R, Joens T, Braicu EI, Dimitrova D, Mellstedt H, Darb-Esfahani S, Denkert C, Lindhofer H, Fotopoulou CSJ (2013) Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer. Int J Gynecol Cancer 23:797–802PubMedCrossRef Pietzner K, Woopen H, Richter R, Joens T, Braicu EI, Dimitrova D, Mellstedt H, Darb-Esfahani S, Denkert C, Lindhofer H, Fotopoulou CSJ (2013) Expression of epithelial cell adhesion molecule in paired tumor samples of patients with primary and recurrent serous ovarian cancer. Int J Gynecol Cancer 23:797–802PubMedCrossRef
Zurück zum Zitat Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO (2005) E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46:685–693PubMedCrossRef Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO (2005) E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46:685–693PubMedCrossRef
Zurück zum Zitat Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE (2009) Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 69:753–757PubMedCentralPubMedCrossRef Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE (2009) Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 69:753–757PubMedCentralPubMedCrossRef
Zurück zum Zitat Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E et al (2008) Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 14:5849–5855PubMedCrossRef Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E et al (2008) Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res 14:5849–5855PubMedCrossRef
Zurück zum Zitat Schmidt M, Petry IB, Böhm D, Lebrecht A, Von Törne C, Gebhard S et al (2011) Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer. Breast Cancer Res Treat 125:637–646PubMedCrossRef Schmidt M, Petry IB, Böhm D, Lebrecht A, Von Törne C, Gebhard S et al (2011) Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer. Breast Cancer Res Treat 125:637–646PubMedCrossRef
Zurück zum Zitat Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MHT et al (2004) Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 10:2659–2669PubMedCrossRef Seligson DB, Pantuck AJ, Liu X, Huang Y, Horvath S, Bui MHT et al (2004) Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma. Clin Cancer Res 10:2659–2669PubMedCrossRef
Zurück zum Zitat Shim HS, Yoon BS, Cho NH (2009) Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma. Hum Pathol 40:693–698PubMedCrossRef Shim HS, Yoon BS, Cho NH (2009) Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma. Hum Pathol 40:693–698PubMedCrossRef
Zurück zum Zitat Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 2014(64):9–29CrossRef Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics. CA Cancer J Clin 2014(64):9–29CrossRef
Zurück zum Zitat Songun I, Litvinov SV, Van de Velde CJH, Pals ST, Hermans J, Van Krieken JHJM (2005) Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer 92:1767–1772PubMedCentralPubMedCrossRef Songun I, Litvinov SV, Van de Velde CJH, Pals ST, Hermans J, Van Krieken JHJM (2005) Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer. Br J Cancer 92:1767–1772PubMedCentralPubMedCrossRef
Zurück zum Zitat Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Bäuerle PA et al (2006) Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 103:483–488PubMedCrossRef Spizzo G, Went P, Dirnhofer S, Obrist P, Moch H, Bäuerle PA et al (2006) Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 103:483–488PubMedCrossRef
Zurück zum Zitat Stoecklein NH, Siegmund A, Scheunemann P, Luebke AM, Erbersdobler A, Verde PE et al (2006) Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker. BMC Cancer 6:165PubMedCentralPubMedCrossRef Stoecklein NH, Siegmund A, Scheunemann P, Luebke AM, Erbersdobler A, Verde PE et al (2006) Ep-CAM expression in squamous cell carcinoma of the esophagus: a potential therapeutic target and prognostic marker. BMC Cancer 6:165PubMedCentralPubMedCrossRef
Zurück zum Zitat Tai K-Y, Shiah S-G, Shieh Y-S, Kao Y-R, Chi C-Y, Huang E et al (2007) DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene 26:3989–3997PubMedCrossRef Tai K-Y, Shiah S-G, Shieh Y-S, Kao Y-R, Chi C-Y, Huang E et al (2007) DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression. Oncogene 26:3989–3997PubMedCrossRef
Zurück zum Zitat Varga M, Obrist P, Schneeberger S, Mu G, Felgel-farnholz C, Fong D et al (2004) Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10:3131–3136PubMedCrossRef Varga M, Obrist P, Schneeberger S, Mu G, Felgel-farnholz C, Fong D et al (2004) Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 10:3131–3136PubMedCrossRef
Metadaten
Titel
Overexpression of epithelial cell adhesion molecule protein is associated with favorable prognosis in an unselected cohort of ovarian cancer patients
verfasst von
Marco Johannes Battista
Cristina Cotarelo
Sina Jakobi
Joscha Steetskamp
Georgios Makris
Isabel Sicking
Veronika Weyer
Marcus Schmidt
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2014
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1672-9

Weitere Artikel der Ausgabe 7/2014

Journal of Cancer Research and Clinical Oncology 7/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.